For the first time, researchers at the universities of Basel and Oxford have identified all genes regulated by the protein Foxn1. The results show that Foxn1 not only plays a crucial role in development of the thymus in the embryo, but it also regulates vital functions in the developed, postnatal organ.
The decryption of the protein's functions is important in the understanding and treatment of autoimmune diseases, vaccination responses in old age and defense against tumor cells. The study was published in the journal Nature Immunology.
Like all vertebrate animals, humans use T cells in immune defense in order to protect the body against infections and malignant cells. Immune cells mature in the thymus, an organ located between the sternum and heart, during the embryonic stage, but they reach full functionality only when they interact with thymus epithelial cells -- the teachers of the T cell, so to speak. The thymus begins to age from the second year of life.
Healthy adults do not directly depend on the work of the thymus; however, the organ's function becomes important again once the body requires new T cells -- for example, after chemotherapy or a bone marrow transplant. To prevent the patient from remaining highly immune-deficient, thymic epithelial cells have to instruct the generation of new T cells.
Genome map of the regulator Foxn1
Researchers at the University of Basel, the University Children's Hospital Basel and the University of Oxford have now succeeded in identifying in thymic epithelial cells the DNA sequence bound by the protein. The team, led by Professor Georg A. Holländer, was able to create a genome-wide map that lists all the DNA segments regulated by Foxn1. It emerged that Foxn1 controls almost all functions of the thymus, in whole or in part. "The protein is not only involved in the development of the organ, it also remains essential for its function throughout a person's life," says the immunologist.
The research results provide important insights into the regulatory functions of thymic epithelial cells and could contribute to the development of new strategies for maintaining the thymus function in old age. "Now that we know exactly what Foxn1 does, we can think about how we can keep the thymus functioning in old age to reduce the risk of autoimmune disease and increased susceptibility to infections and tumors," says Holländer.